Madrigal Pharmaceuticals
MDGL
MDGL
133 hedge funds and large institutions have $876M invested in Madrigal Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $1.09B → $876M (-$216M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
69% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 26
Holders
133
Holding in Top 10
1
Calls
$9.87M
Puts
$5.91M
Top Buyers
| 1 | +$35.4M | |
| 2 | +$12M | |
| 3 | +$10.9M | |
| 4 |
Goldman Sachs
New York
|
+$3.66M |
| 5 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$3.07M |
Top Sellers
| 1 | -$45.4M | |
| 2 | -$12.8M | |
| 3 | -$10.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$9.56M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$7.12M |